XT
IRD

XTX Topco’s Opus Genetics IRD Stock Holding History

XTX Topco’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$592K Buy
144,095
+127,391
+763% +$594K 0.01% 2295
2026
Q1 		$76K Sell
16,704
-7,033
-30% -$24.3K ﹤0.01% 3193
2025
Q4 		$47.7K Sell
23,737
-28,020
-54% -$56.9K ﹤0.01% 2846
2025
Q3 		$85.4K Buy
51,757
+35,949
+227% +$44.7K ﹤0.01% 2062
2025
Q2 		$14.9K Buy
+15,808
New +$14.6K ﹤0.01% 2206
2025
Q1 		– Sell
-43,578
Closed -$51.9K – 3260
2024
Q4 		$51.9K Buy
43,578
+15,686
+56% +$18K ﹤0.01% 1887
2024
Q3 		$36.5K Buy
+27,892
New +$42.9K ﹤0.01% 1747
2023
Q3 		– Sell
-16,911
Closed -$73.4K – 2088
2023
Q2 		$73.4K Buy
+16,911
New +$80.3K 0.01% 1199

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

XTX Topco's IRD Position: Q2 2026 in Review

XTX Topco increased its Opus Genetics (IRD) stake by 763% in Q2 2026, buying an estimated $594K and bringing the position to 144,095 shares worth $592K. The position accounts for 0.01% of the portfolio, ranked #2295.

XTX Topco first reported a position in IRD in Q2 2023 and has held it in 8 quarters since. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • XTX Topco held 144,095 shares of Opus Genetics worth $592K as of Q2 2026.
  • XTX Topco bought 127,391 Opus Genetics shares in Q2 2026, an estimated $594K.
  • Opus Genetics made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2295 holding.
  • XTX Topco first reported a position in Opus Genetics in Q2 2023 and has held it in 8 quarters since.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.